Allscripts Announces Share Repurchase Program
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/25/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- FDA approves Tylenol with Naproxen as first OTC combo pain reliever
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Outlook Therapeutics (OTLK) halted, news pending
Allscripts (MDRX) Approves $150M Buyback
November 30, 2015 4:32 PM ESTAllscripts (NASDAQ: MDRX) announced today that its Board of Directors approved a share repurchase program under which Allscripts may purchase up to $150 million of its common stock through December 31, 2018.
Repurchases will be made from cash on hand as well as a portion of the free cash flow expected to be generated from the business over the next three years. The share... More
